loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 200878 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Apotex Fermentation Inc.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 APOTEX CORP (3)

    filter

    01 TABLET, EXTENDED RELEASE;ORAL (3)

    filter

    01 DISCN (3)

    filter

    01 VERAPAMIL HYDROCHLORIDE (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    VERAPAMIL HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    120MG
    2012-04-20
    200878
    VERAPAMIL HYDROCHL...
    DISCN
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    VERAPAMIL HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    180MG
    2012-04-20
    200878
    VERAPAMIL HYDROCHL...
    DISCN
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    VERAPAMIL HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED R...
    240MG
    2012-04-20
    200878
    VERAPAMIL HYDROCHL...
    DISCN
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 200878

    Looking for FDA Orange Book APPLICATION 200878 3

    19

    Apotex Fermentation Inc., based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is VERAPAMIL HYDROCHLORIDE, with a corresponding application number 200878.

    Regulatory Information DISCN

    With a dosage strength 120MG

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug No

    Approved since 2012-04-20

    18

    Apotex Fermentation Inc., based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is VERAPAMIL HYDROCHLORIDE, with a corresponding application number 200878.

    Regulatory Information DISCN

    With a dosage strength 180MG

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug No

    Approved since 2012-04-20

    17

    Apotex Fermentation Inc., based in Canada, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is VERAPAMIL HYDROCHLORIDE, with a corresponding application number 200878.

    Regulatory Information DISCN

    With a dosage strength 240MG

    Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

    Reference Listed Drug No

    Approved since 2012-04-20

    Post Enquiry
    POST ENQUIRY